{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:17:03Z","timestamp":1788243423791,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Somatotropinomas are the main cause of acromegaly. Surgery is the primary and most efficient method of treatment. The study aimed to compare the radicality of small-sized and medium (&amp;lt;30 mm) somatotropinoma removal and the incidence of postoperative complications in patients with acromegaly when using microscopic and endoscopic techniques.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this randomized controlled trial, a total of 83 patients with acromegaly underwent transspheroidal endoscopy or microscopic surgery. Somatotropinoma was the cause of acromegaly in all cases. Patients were randomly divided into two comparison groups depending on the applied surgical technique. Group 1 (n = 40) consisted of patients who underwent adenomectomy with transnasal transsphenoidal access by a microscope. Group 2 (n = 43) included patients who underwent the same surgical procedure with an endoscope. The following indicators were assessed: radicality of tumor removal, treatment effectiveness, postoperative complications, and remission rate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study has shown that removal of somatotropinoma in patients with acromegaly using endoscopic technique increases the radicality of tumor removal in comparison with microscopic technique. Total removal of somatotropinoma was successful in 88.4% of cases when using the endoscopic technique. Secondly, the segmentation of patients according to their tumor characteristics poses challenges, primarily owing to the rarity of acromegaly as a disease. The difference between groups was not statistically significant (p=1.02). There were no statistically significant differences in basal GH level and IGF-1 level between groups (p=0.546 and p=0.784, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Endonasal transsphenoidal endoscopic adenomectomy is proven efficacy, a less traumatic degree, and higher somatotropinoma removal radicality. Both surgical methods lead to disease remission.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1128345","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:13:51Z","timestamp":1694430831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative effectiveness of endoscopic and microscopic adenoma removal in acromegaly"],"prefix":"10.3389","volume":"14","author":[{"given":"Natalya","family":"Vassilyeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natmir","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Kirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Diatlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09534-8","article-title":"Aggressive pituitary tumours in the young and elderly","volume":"21","author":"Tatsi","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: A consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"dgz096","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00147","article-title":"New epidemiological, clinical and economic data for patients with acromegaly in Bulgaria","volume":"8","author":"Kamusheva","year":"2020","journal-title":"Front Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.33029\/2304-9529-2022-11-2-71-82","article-title":"Problems of diagnostics and treatment of acromegalia","volume":"2","author":"Pronin","year":"2022","journal-title":"Endocrinol News Opin Train"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-19-0316","article-title":"Individualised management of acromegaly","volume":"181","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1630-4","article-title":"Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database","volume":"61","author":"Gatto","year":"2018","journal-title":"Endocrine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"dgaa444","DOI":"10.1210\/clinem\/dgaa444","article-title":"Cost-effectiveness and efficacy of a novel combination regimen in acromegaly: A prospective, randomized trial","volume":"105","author":"Bonert","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3390\/jcm8111962","article-title":"The clinicopathological spectrum of acromegaly","volume":"8","author":"Akirov","year":"2019","journal-title":"J Clin Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42000-020-00235-5","article-title":"Clinical presentation and management of acromegaly in elderly patients","volume":"1","author":"Ceccato","year":"2020","journal-title":"Hormones"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.01.011","article-title":"Acromegaly and vertebral fractures: facts and questions","volume":"31","author":"Giustina","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0058-5","article-title":"A Consensus Statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0794","article-title":"All-cause mortality in patients with acromegaly treated with pegvisOmant: an ACROSTUDY analysis","volume":"182","author":"Tritos","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.17925\/EE.2018.14.2.57","article-title":"Updates in diagnosis and treatment of acromegaly","volume":"14","author":"Zahr","year":"2018","journal-title":"Eur Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0554","article-title":"Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome","volume":"96","author":"Jane","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-017-3318-6","article-title":"Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications","volume":"159","author":"Chen","year":"2017","journal-title":"Acta Neurochir"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.01.110","article-title":"Endoscopic endonasal versus microscopic transsphenoidal surgery for recurrent and\/or residual pituitary adenomas","volume":"101","author":"Esquenazi","year":"2017","journal-title":"World Neurosurg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-015-0613-7","article-title":"Endoscopic versus microscopic approach for surgical treatment of acromegaly","volume":"38","author":"Fathalla","year":"2015","journal-title":"Neurosurg Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.wneu.2016.10.029","article-title":"Endoscopic endonasal versus microsurgical transsphenoidal approach for growth hormone-secreting pituitary adenomas-systematic review and meta-analysis","volume":"97","author":"Phan","year":"2017","journal-title":"World Neurosurg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.09.004","article-title":"Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly","volume":"126","author":"Sarkar","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17116\/neiro201780795-107","article-title":"Surgical treatment for pituitary adenomas","volume":"1","author":"Kalinin","year":"2017","journal-title":"Issues Neurosurg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"1","author":"Fleseriu","year":"2020","journal-title":"Pituitary"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.surneu.2003.08.036","article-title":"Giant pituitary tumours: a study based on surgical treatment of 118 cases","volume":"61","author":"Goel","year":"2004","journal-title":"Surg Neurol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.14341\/2306-3513-2007-1-24-27","article-title":"Surgical treatment of patients with Itsenko-Cushing\u2019s disease","volume":"1","author":"Grigoriev","year":"2007","journal-title":"Endocr Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4103\/ajns.AJNS_160_16","article-title":"Endoscopic versus microscopic pituitary adenoma surgery: an institutional experience","volume":"13","author":"Prajapati","year":"2018","journal-title":"Asian J Neurosurg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0893-3","article-title":"Endoscopic vs. microscopic transsphenoidal surgery for Cushing\u2019s disease: a systematic review and meta-analysis","volume":"21","author":"Broersen","year":"2018","journal-title":"Pituitary."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.806855","article-title":"Endoscopic vs. microscopic transsphenoidal surgery for the treatment of pituitary adenoma: a meta-analysis","volume":"8","author":"Chen","year":"2022","journal-title":"Front Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyz201","article-title":"Endoscopic transnasal trans-sphenoidal approach for pituitary adenomas: a comparison to the microscopic approach cohort by propensity score analysis","volume":"86","author":"Casta\u00f1o-Leon","year":"2020","journal-title":"Neurosurgery."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1023\/b:neon.0000041886.61149.ab","article-title":"Transsphenoidal and transcranial surgery for pituitary adenomas","volume":"69","author":"Couldwell","year":"2004","journal-title":"J Neurooncol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.JNS141083","article-title":"Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification","volume":"122","author":"Micko","year":"2015","journal-title":"J Neurosurg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1128345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:14:01Z","timestamp":1694430841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1128345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":36,"alternative-id":["10.3389\/fendo.2023.1128345"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1128345","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"article-number":"1128345"}}